Precigen officer plans sale of 79,166 shares

Rhea-AI Filing Summary

PRECIGEN, INC. (PGEN) received a Rule 144 notice relating to a potential sale of its common stock. An officer, Phillip Tennant, has filed to sell up to 79,166 shares of PRECIGEN common stock through Fidelity Brokerage Services LLC on or after 08/25/2026 on NASDAQ. The shares are tied to a stock option exercise paid in cash and have an aggregate market value of $593,745.00 as stated in the notice.

Key Figures

Shares to be sold: 79,166 shares of common stock Aggregate market value: $593,745.00 Planned sale date: 08/25/2026 +1 more

4 metrics

Shares to be sold 79,166 shares of common stock Securities information section for intended Rule 144 sale

Aggregate market value $593,745.00 Listed with the 79,166 shares of PRECIGEN common stock

Planned sale date 08/25/2026 Date associated with the securities to be sold on NASDAQ

Issuer phone number 301-556-9900 Contact phone number for PRECIGEN, INC.

Key Terms

Rule 144, stock option exercise, attorney-in-fact, aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

stock option exercise financial

"Common | 08/25/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

attorney-in-fact regulatory

"as attorney-in-fact for Phillip Tennant"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

aggregate market value financial

"Common | Fidelity Brokerage Services LLC ... | 79166 | 593745.00"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the Form 144 filing disclose for PRECIGEN, INC. (PGEN)?

The filing discloses that an officer, Phillip Tennant, has notified of an intended sale of up to 79,166 shares of PRECIGEN common stock under Rule 144, to be sold through Fidelity Brokerage Services LLC on or after 08/25/2026 on NASDAQ.

How many PRECIGEN (PGEN) shares are covered by this Form 144 notice?

The notice covers up to 79,166 shares of PRECIGEN, INC. common stock. These shares are associated with a stock option exercise and are listed with an aggregate market value of $593,745.00 in the filing.

What is the aggregate market value of the PRECIGEN (PGEN) shares in the Form 144?

The Form 144 lists an aggregate market value of $593,745.00 for the 79,166 shares of PRECIGEN common stock that may be sold. This figure appears in the securities information section of the notice.

When may the PRECIGEN (PGEN) shares be sold under this Form 144?

The Form 144 states a date of 08/25/2026 in connection with the potential sale of 79,166 shares of PRECIGEN common stock on NASDAQ and with the related stock option exercise paid in cash.

Who is the broker named in the PRECIGEN (PGEN) Form 144 filing?

The broker named is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917. The filing indicates that the 79,166 shares of PRECIGEN common stock are to be sold through this broker on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 01:53 PM Accepted by SEC EDGAR 08/25/2026 - 01:53 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002030874
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PRECIGEN, INC.
SEC File Number	001-36042
Address of Issuer	20374 SENECA MEADOWS PARKWAY GERMANTOWN MARYLAND 20876
Phone	301-556-9900
Name of Person for Whose Account the Securities are To Be Sold	Tennant Phil
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	79166	593745.00	358035247	08/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/25/2026	Stock Option Exercise	Issuer			79166	08/25/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Phillip Tennant
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)